Voyageur Pharmaceuticals Ltd VYYRF

Primary Symbol: V.VM

Healthcare Drug Manufacturers - Specialty & Generic

Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine Active Pharmaceutical Ingredients (API) and offers high-performance imaging contrast agents. The Company is focused on vertically integrating the barium and iodine contrast market, and aims at producing its own barium, iodine, and endo fullerenes. The Company’s products include SmoothX, SmoothHD, SmoothLD, VisionHD, VisionLD and V-Gas. SmoothX (2%w/v) is a contrast medium for use in computed tomography (CT) of the gastrointestinal tract. VisionHD is a high-density (98% w/w) barium powder suspension tailored for double-contrast radiographic examination of the gastrointestinal tract, esophagus, stomach and duodenum. It also owns a 100% interest in the Frances Creek barium sulfate (barite) project, which is a rare grade mineral suitable for the pharmaceutical marketplace that is intended to replace the current synthetic products with quality imaging products.

TSXV:VM - Post by User

Voyageur Pharmaceuticals Ltd > Something Fundamentally Wrong

<< Previous

Bullboard Posts

Next >>

Comment by WarrantOfficeron May 15, 2024 7:28pm

183 Views

Post# 36042287

RE:RE:RE:RE:RE:RE:RE:Something Fundamentally Wrong

If the chickens are not laying eggs, it would be nice to know. The fact that there was not a PR stating that Voyageur is proud to inform shareholders that their anticipated contrast media product line is now available...........and thanking all involved for their hard work, dedication and patience in achieving this milestone.

BUT...there is nothing. Social media platforms are free to utilize...BUT there is nothing, which further demonstrates managements lack lustre efforts of keeping shareholders informed. The picture they have painted is a lack of ethos and ethics towards their shareholders.

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario